BioVie's degenerative dementia drug candidate to be presented at the 78th Annual Scientific Convention of the Society of Biological Psychiatry.
BioVie Inc (NASDAQ:BIVI) announced Thursday that a data abstract from its Phase 2 open-label trial of its degenerative dementia drug candidate has been...
Source: proactiveinvestors.com